Trevi Therapeutics, Inc.
TRVI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001563880
In the last 90 days, Trevi Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 218 institutions reported holding it in 13F filings for Q2 2026, worth $2.76B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q1 2022
Institutional positions in Trevi Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +6 vs. Q4 2021
- Shares held
- 7.16M
- −6.01M (−45.6%) vs. Q4 2021
- Total value
- $32.9M
- +$22.6M (+219.8%) vs. Q4 2021
- New holders
- 9
- 4 more added
- Sold out
- 3
- 5 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRVI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 218 | $2.76B |
| Q1 2026 | 198 | $1.61B |
| Q4 2025 | 184 | $1.63B |
| Q3 2025 | 164 | $1.18B |
| Q2 2025 | 154 | $627.2M |
| Q1 2025 | 137 | $554.3M |
| Q4 2024 | 110 | $329.5M |
| Q3 2024 | 93 | $194.1M |
| Q2 2024 | 77 | $166.6M |
| Q1 2024 | 80 | $177.9M |
| Q4 2023 | 63 | $70.0M |
| Q3 2023 | 55 | $106.1M |
| Q2 2023 | 53 | $116.7M |
| Q1 2023 | 36 | $80.4M |
| Q4 2022 | 37 | $83.3M |
| Q3 2022 | 40 | $70.5M |
| Q2 2022 | 32 | $80.8M |
| Q1 2022 | 23 | $32.9M |
| Q4 2021 | 17 | $10.3M |
| Q3 2021 | 18 | $17.4M |
| Q2 2021 | 17 | $28.1M |
| Q1 2021 | 19 | $35.6M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Trevi Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 73 | $0 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 589 | $1.00K | 0.00% | +589 | New |
| UBS Group AG | 1,624 | $4.00K | 0.00% | +1,624 | New |
| First Manhattan Co | 2,500 | $5.00K | 0.00% | −1,000−28.6% | Reduced |
| Curi Capital | 4,744 | $10.0K | 0.00% | +4,744 | New |
| Tower Research Capital LLC (TRC) | 9,477 | $21.0K | 0.00% | +1,160+13.9% | Added |
| LPL Financial LLC | 10,000 | $22.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 11,414 | $25.0K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 15,000 | $33.0K | 0.00% | +15,000 | New |
| Virtu Financial LLC | 20,055 | $44.0K | 0.00% | +20,055 | New |
| Marshall Wace, LLP | 23,402 | $52.0K | 0.00% | +23,402 | New |
| United Bank | 26,700 | $59.0K | 0.01% | +26,700 | New |
| BlackRock Inc. | 33,439 | $73.0K | 0.00% | −11,509−25.6% | Reduced |
| State Street Corp | 36,842 | $81.0K | 0.00% | +36,842 | New |
| Geode Capital Management, LLC | 72,744 | $160.0K | 0.00% | +23,667+48.2% | Added |
| Bridgeway Capital Management, LLC | 75,000 | $165.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 84,880 | $187.0K | 0.00% | −36,612−30.1% | Reduced |
| WealthTrust Axiom LLC | 98,500 | $216.0K | 0.07% | +70,000+245.6% | Added |
| Renaissance Technologies LLC | 116,000 | $255.0K | 0.00% | −221,400−65.6% | Reduced |
| Vanguard Group Inc | 152,831 | $336.0K | 0.00% | +10,780+7.6% | Added |
| MAI Capital Management | 1,541,471 | $3.39M | 0.06% | +1,541,471 | New |
| TPG GP A, LLC | 4,824,883 | $10.6M | 0.13% | 00.0% | Unchanged |
| NEA Management Company, LLC | 2,798 | $17.1M | 0.55% | −5,937,998−100.0% | Reduced |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −1,512,344−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −49,849−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −10,461−100.0% | Sold out |